BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8590055)

  • 1. Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats.
    Jenkins TA; Chai SY; Howells DW; Mendelsohn FA
    Brain Res; 1995 Sep; 691(1-2):213-6. PubMed ID: 8590055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms.
    Garside S; Furtado JC; Mazurek MF
    Neuroscience; 1996 Dec; 75(4):1065-74. PubMed ID: 8938742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.
    Mendelsohn FA; Jenkins TA; Berkovic SF
    Brain Res; 1993 Jun; 613(2):221-9. PubMed ID: 7514480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo.
    Brown DC; Steward LJ; Ge J; Barnes NM
    Br J Pharmacol; 1996 May; 118(2):414-20. PubMed ID: 8735646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opponent-process theory and drug conditioning: an assessment for conditioned stimulant-induced movement.
    Carey RJ; Damianopoulos EN
    Behav Brain Res; 1992 Nov; 51(2):139-47. PubMed ID: 1466780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circling behavior following unilateral kainic acid injections into rat striatum.
    Taylor RJ; Reavill C; Jenner P; Marsden CD
    Eur J Pharmacol; 1981 Dec; 76(2-3):211-22. PubMed ID: 7333356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
    Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
    Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor effects of imidazoline I2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Macinnes N; Duty S
    Br J Pharmacol; 2004 Dec; 143(8):952-9. PubMed ID: 15545290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
    Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
    Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin II on a spinal nociceptive reflex in the rat: receptor and mechanism of action.
    Toma N; Sgambato V; Couture R
    Life Sci; 1997; 61(5):503-13. PubMed ID: 9247320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
    Hogarty DC; Speakman EA; Puig V; Phillips MI
    Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan influences behavioural effects of angiotensin II in rats.
    Kułakowska A; Karwowska W; Wiśniewski K; Braszko JJ
    Pharmacol Res; 1996; 34(3-4):109-15. PubMed ID: 9051700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of specific dopamine lesions and dopamine receptor sensitivity on angiotensin II- and carbachol-induced thirst in rats.
    Sumners C; Woodruff GN; Poat JA
    Psychopharmacology (Berl); 1981; 73(2):180-3. PubMed ID: 6785812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
    Viswanathan M; de Oliveira AM; Wu RM; Chiueh CC; Saavedra JM
    Cell Mol Neurobiol; 1994 Feb; 14(1):99-104. PubMed ID: 7954664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of DUP-753 on the drinking responses of rats to central administration of noradrenaline and angiotensin II and to dehydration.
    Reis LC; Saad WA; Camargo LA; Renzi A; Menani V; Silveira JE; Saad WA
    Braz J Med Biol Res; 1996 Apr; 29(4):507-10. PubMed ID: 8736116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    Gorbea-Oppliger VJ; Fink GD
    J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
    Cox SL; Story DF; Ziogas J
    Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.
    Mertens B; Varcin M; Michotte Y; Sarre S
    Eur J Neurosci; 2011 Oct; 34(7):1141-8. PubMed ID: 21936877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.